Sirolimus for non‐progressive NF1‐associated plexiform neurofibromas: An NF clinical trials consortium phase II study期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Sirolimus for non‐progressive NF1‐associated plexiform neurofibromas: An NF clinical trials consortium phase II study

Authors:	Brian Weiss MD Brigitte C. Widemann MD Pamela Wolters PhD Eva Dombi MD Alexander A. Vinks PharmD PhD Alan Cantor PhD Bruce Korf MD PhD John Perentesis MD David H. Gutmann MD PhD Elizabeth Schorry MD Roger Packer MD Michael J. Fisher MD

Affiliation:	1. Division of Oncology, Cincinnati Children's Hospital Medical Center, , Cincinnati, Ohio;2. Department of Pediatric Oncology, National Cancer Institute, , Bethesda, Maryland;3. Department of Pediatrics, Cincinnati Children's Hospital Medical Center, , Cincinnati, Ohio;4. Department of Genetics, University of Alabama at Birmingham, , Birmingham, Albama;5. Department of Neurology, Washington University in St. Louis, , St. Louis, Missouri;6. Department of Genetics, Cincinnati Children's Hospital Medical Center, , Cincinnati, Ohio;7. Children's National Medical Center, , Washington, District of Columbia;8. Division of Oncology, Philadelphia Children's Hospital, , Philadelphia, Pennsylvania

Abstract:

Keywords:	clinical trials mTOR neurofibromatosis new agents solid tumors